NDC 10122-502 – Revcovi

Elapegademase 1.6 mg/mL · Injection · Intramuscular

Human Prescription Drug 1 recall

Product NDC10122-502

Product details

Brand name
Revcovi
Generic name
Elapegademase-lvlr
Labeler
Chiesi USA, Inc.
Dosage form
Injection
Route
Intramuscular
Marketing category
BLA · BLA761092
Marketed since
October 5, 2018
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Revcovi →

Package NDC codes (1)

Package NDCDescriptionSince
10122-502-011 VIAL in 1 CARTON (10122-502-01) / 1.5 mL in 1 VIALOct 5, 2018

Recalls mentioning this NDC